Abstract:ObjectivesTo evaluate the influence of pathological factors, such as fibrosis stage and histological grade, on the Liver Imaging Reporting and Data System (LI-RADS) v2017 category of contrast-enhanced ultrasonography (CEUS) in patients with high risk of hepatocellular carcinoma (HCC).Materials and methodsBetween June 2015 and December 2016, 441 consecutive patients at high risk of HCC with 460 pathologically proven HCCs were enrolled in this retrospective study. All patients underwent a CEUS examination. The major features (arterial phase hyperenhancement, late and mild washout) were assessed, and LI-RADS categories were assigned according to CEUS LI-RADS v2017. CEUS LI-RADS categories and major features were compared in different histological grades and fibrosis stages.ResultsThe CEUS LR-5 category was more frequently assigned in the low-grade group (151/280) than in the high-grade group (66/159) (p = 0.013), whereas the LR-TIV category was more frequently assigned in the high-grade group (36/159) than in the low-grade group (40/280) (p = 0.035). CEUS LI-RADS category was not significantly different among different fibrosis stages (p ≥ 0.05). Arterial phase hyperenhancement (APHE) and the hepatic fibrosis stage showed a significant correlation in HCCs ≥ 2 cm and the low-grade group (p = 0.027 and p = 0.003, respectively). No major features of CEUS LI-RADS showed statistically significant differences between the low- and high-grade groups (p ≥ 0.05).ConclusionHepatic fibrosis stage can influence APHE but showed no impact on the CEUS LI-RADS classification, whereas the histological grade of HCC influenced the LR-5 and LR-TIV categories.Key Points• Histological grade influenced CEUS LR-5 and LR-TIV category (p = 0.013 and p = 0.035 respectively). Low-grade HCCs occurred more frequently in LR-5 category whereas high-grade HCCs occurred more frequently in LR-TIV category.• Fibrosis stage shows significant influence on APHE on HCCs of the size ≥ 2 cm and low-grade group (p = 0.027 and p = 0.003, respectively).• Hepatic fibrosis stage and HCC histological grade exhibited limited impact on CEUS LI-RADS. CEUS LI-RADS may be feasible for diagnosing HCC in patients regardless of histological grade and fibrosis stage.

Non-radiomics Imaging (US-CEUS) Features and Clinical Text Features: Correlation with Microvascular Invasion and Tumor Grading in Hepatocellular Carcinoma.

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Profiling Hepatocellular Carcinoma Aggressiveness with Contrast-Enhanced Ultrasound and Gadoxetate Disodium-Enhanced MRI: an Intra-Individual Comparative Study Based on the Liver Imaging Reporting and Data System.

Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 Cm: Biological Characteristics and Patient Outcomes

Parametric Imaging with Contrast-Enhanced Ultrasound for Differentiating Hepatocellular Carcinoma from Metastatic Liver Cancer.

Correlation Between Enhancement Pattern of Hepatocellular Carcinoma on Real-Time Contrast-Enhanced Ultrasound and Tumour Cellular Differentiation on Histopathology

Study on Correlation Between Two-Dimensional Ultrasound, Contrast-Enhanced Ultrasound and Microvascular Invasion in Hepatocellular Carcinoma.

Parametric Imaging with Contrast-Enhanced Ultrasound: Usefulness for Characterization of Dynamic Effects of Microvascularization for Hepatocellular Carcinoma and Focal Nodular Hyperplasia.

Comparison of Sonazoid-Contrast‑Enhanced Ultrasound and Gd‑EOB‑DTPA‑Enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma

0605: Treatment Response Evaluation with 3D Contrast-Enhanced Ultrasound for Liver Cancer after Local Therapies

Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade

Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma

Prognostic and Pathological Implications of Contrast-Enhanced Ultrasound Features in Hepatocellular Carcinoma.

The Interreader Agreement and Validation of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System.

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M

Nodules Identified on Surveillance Ultrasound for HCC

Correlation analysis of contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification with hepatocellular carcinoma differentiation and Ki-67 index

Radiomics-Based Machine Learning Classification Strategy for Characterization of Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound in High-Risk Patients with LI-RADS Category M Nodules